Borrowings | Note 12 – Borrowings Our Company’s borrowings at March 31, 2023 and December 31, 2022, net of deferred financing costs and including the impact of interest rate derivatives on effective interest rates, are summarized below: As of March 31, 2023 (Dollars in thousands) Maturity Date Contractual Facility Balance, Gross Balance, Net (1) Stated Interest Rate Effective Interest Rate Denominated in USD Trust Preferred Securities (US) April 30, 2027 $ 27,913 $ 27,913 $ 27,005 8.80 % 8.80 % Bank of America Credit Facility (US) September 4, 2024 26,000 26,000 25,823 10.50 % 10.50 % Cinemas 1, 2, 3 Term Loan (US) July 3, 2023 22,341 22,341 22,167 6.63 % 6.63 % Minetta & Orpheum Theatres Loan (US) (2) November 1, 2023 8,000 8,000 7,982 6.00 % 5.15 % U.S. Corporate Office Term Loan (US) January 1, 2027 8,607 8,607 8,550 4.64 % / 4.44 % 4.61 % Union Square Financing (US) (3) May 6, 2024 55,000 43,000 42,571 11.68 % 7.40 % Purchase Money Promissory Note (US) September 18, 2024 1,149 1,149 1,149 5.00 % 5.00 % Denominated in foreign currency ("FC") (4) NAB Corporate Term Loan (AU) June 30, 2024 67,712 67,712 67,653 5.43 % 5.43 % Westpac Bank Corporate (NZ) January 1, 2024 8,679 8,679 8,679 7.45 % 7.45 % $ 225,401 $ 213,401 $ 211,579 (1) Net of deferred financing costs amounting to $ 1.8 million. (2) The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15 %. (3) The interest rate derivative associated with the Union Square loan provides for a maximum effective rate of 7.40 %. (4) The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of March 31, 2023. As of December 31, 2022 (Dollars in thousands) Maturity Date Contractual Facility Balance, Gross Balance, Net (1) Stated Interest Rate Effective Interest Rate Denominated in USD Trust Preferred Securities (US) April 30, 2027 $ 27,913 $ 27,913 $ 26,950 8.41 % 8.41 % Bank of America Credit Facility (US)(5) March 1, 2024 26,750 26,750 26,663 10.00 % 10.00 % Cinemas 1, 2, 3 Term Loan (US)(5) April 1, 2023 22,455 22,455 22,208 6.63 % 6.63 % Minetta & Orpheum Theatres Loan (US)(2) November 1, 2023 8,000 8,000 7,974 7.12 % 6.00 % U.S. Corporate Office Term Loan (US) January 1, 2027 8,674 8,674 8,613 4.64 % / 4.44 % 4.64 % Union Square Financing (US) (3) May 6, 2024 55,000 43,000 42,484 11.25 % 7.40 % Purchase Money Promissory Note (US) September 18, 2024 1,333 1,333 1,333 5.00 % 5.00 % Denominated in foreign currency ("FC")(4) NAB Corporate Term Loan (AU) June 30, 2024 68,731 68,731 68,662 4.82 % 4.82 % Westpac Bank Corporate (NZ) January 1, 2024 8,777 8,777 8,777 6.95 % 6.95 % Total $ 227,633 $ 215,633 $ 213,664 (1) Net of deferred financing costs amounting to $ 2.0 million. (2) The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15 %. (3) The interest rate derivative associated with the Union Square loan provides for an effective fixed rate of 7.40 %. (4) The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2022. (5) This financing facility was extended after December 31, 2022. Our loan arrangements are presented, net of the deferred financing costs, on the face of our consolidated balance sheet as follows: March 31, December 31, Balance Sheet Caption (Dollars in thousands) 2023 2022 Debt - current portion $ 47,345 $ 37,279 Debt - long-term portion 136,473 148,688 Subordinated debt - current portion 756 747 Subordinated debt - long-term portion 27,005 26,950 Total borrowings $ 211,579 $ 213,664 Bank of America Credit Facility Our $ 55.0 million Bank of America facility now matures on September 4, 2024 , following a Q1 2023 loan modification, which, among other things, extended the maturity date from March 1, 2024. The current facility requires monthly repayments of $ 725,000 commencing in May 2023, with a balloon payment upon maturity. Interest is charged at a fixed rate of 3.0 % above the Bank of America Prime rate, which itself has a floor of 1.0 %. Payment-in-kind interest of 0.5 % accrues from January 1, 2024, but will be waived in the event of repayment of the entire debt prior to April 1, 2024. Minetta and Orpheum Theatres Loan On October 12, 2018, we refinanced our $ 7.5 million loan with Santander Bank, which is secured by our Minetta and Orpheum Theatres, with a loan for a five year term of $ 8.0 million. Such modification was not considered to be substantial under U.S. GAAP. U.S. Corporate Office Term Loan On December 13, 2016, we obtained a ten year $ 8.4 million mortgage loan on our Culver City building at a fixed annual interest rate of 4.64 %. On June 26, 2017, we obtained a further $ 1.5 million at a fixed annual interest rate of 4.44 %. Cinemas 1,2,3 Term Loan Our Cinemas 1,2,3 Term Loan, held by Sutton Hill Properties LLC (“SHP”), a 75 % owned subsidiary of RDI, matures on July 3, 2023, following a modification in Q1 of 2023 to extend the maturity date from April 1, 2023. The term loan is with Valley National Bank and carries an interest rate of 4.25 %. Union Square Financing On May 7, 2021, we closed on a new three-year $ 55.0 million loan facility with Emerald Creek Capital secured by our 44 Union Square property and certain limited guarantees. The facility bears a variable interest rate of one month LIBOR plus 6.9 % with a floor of 7.0 % and includes provisions for a prepaid interest and property tax reserve fund. The loan has two 12-month options to extend, and may be repaid at any time, without the payment of any premium. Purchase Money Promissory Note On September 18, 2019, we purchased for $ 5.5 million 407,000 shares of our Class A Common Stock in a privately negotiated transaction under our Share Repurchase Program. Of this amount, $ 3.5 million was paid by the issuance of a Purchase Money Promissory Note, which bears an interest rate of 5.0 % per annum, payable in equal quarterly payments of principal plus accrued interest. The Purchase Money Promissory Note matures on September 18, 2024 . Westpac Bank Corporate Credit Facility (NZ) Our Westpac Corporate Credit Facility for NZ$ 13.8 million matures on January 1, 2024 . The facility currently carries an interest rate and line of credit charge of 2.40 % above the Bank Bill Bid Rate and 1.65 % respectively. Westpac has waived the requirement to test certain covenants for each quarter since the third quarter of 2020, including the current quarter. Australian NAB Corporate Term Loan (AU) Our Revolving Corporate Markets Loan Facility with National Australia Bank (“NAB”) matures on June 30, 2024. It currently consists of (i) a AU$ 100.0 million Corporate Loan facility at 1.75 % above BBSY, of which AU$ 60.0 million is revolving and AU$ 40.0 million is core, (ii) a Bank Guarantee Facility of AU$ 5.0 million at a rate of 1.85 % per annum and (iii) a further AU$ 3.0 million of core debt added in December 2020, relating to the funding of our cinema at Jindalee, Queensland, which is repayable in semi-annual installments of AU$ 500,000 , the first installment being April 30, 2021, until fully repaid on October 31, 2023. |